Search Results - "Racewicz, A."

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)) by Emery, P, Deodhar, A, Rigby, W F, Isaacs, J D, Combe, B, Racewicz, A J, Latinis, K, Abud-Mendoza, C, Szczepanski, L J, Roschmann, R A, Chen, A, Armstrong, G K, Douglass, W, Tyrrell, H

“…This phase III study evaluated the efficacy and safety of rituximab plus methotrexate (MTX) in patients with active rheumatoid arthritis (RA) who had an…”
Get more information

Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data by McClung, M. R., Zanchetta, J. R., Racewicz, A., Roux, C., Benhamou, C.-L., Man, Z., Eusebio, R. A., Beary, J. F., Burgio, D. E., Matzkin, E., Boonen, S., Delmas, P.

“…Summary This study showed that risedronate 150-mg once a month provides similar efficacy and safety at 2 years compared with risedronate 5-mg daily for the…”
Get full text

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis by Delmas, Pierre D, McClung, Michael R, Zanchetta, José R, Racewicz, Artur, Roux, Christian, Benhamou, Claude-Laurent, Man, Zulema, Eusebio, Rachelle A, Beary, John F, Burgio, David E, Matzkin, Ellen, Boonen, Steven

“…Abstract Introduction: Risedronate has been shown to be effective in the treatment of postmenopausal osteoporosis when given orally in daily or weekly doses or…”
Get full text

Safety and tolerability of rituximab in patients with moderate to severe rheumatoid arthritis (RA): Results from the dose-ranging assessment international clinical evaluation of rituximab in RA (dancer) study by Van Vollenhoven, R, Emery, R, Fleischmann, RM, Filipowicz-Sosnowska, A, Szczepanski, L, Racewicz, A, Schechtman, J, Rowe, KA, Tyrrell, H, Li, NF, Sewell, KL

Get full text

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial by Emery, Paul, Fleischmann, Roy, Filipowicz‐Sosnowska, Anna, Schechtman, Joy, Szczepanski, Leszek, Kavanaugh, Arthur, Racewicz, Artur J., van Vollenhoven, Ronald F., Li, Nicole F., Agarwal, Sunil, Hessey, Eva W., Shaw, Timothy M.

“…Objective To examine the efficacy and safety of different rituximab doses plus methotrexate (MTX), with or without glucocorticoids, in patients with active…”
Get full text

Comparative analysis of three treatment regimens for treating gonarthritis with calcitonin, naproxen and flavonoids based on EULAR criteria and visual analogue scale (VAS) by Badurski, J, Jeziernicka, E, Naruszewicz, K, Racewicz, A

“…The newest laboratory and clinical elaborations have described a stimulatory effect of salmon calcitonin (sCT) on cultivated chondrocytes and cartilage…”
Get more information